Associations between Arsenic (13 Oxidation State) Methyltransferase (AS3MT) and N-6 Adenine-specific DNA Methyltransferase1 (N6AMT1) Polymorphisms, Arsenic Metabolism, and Cancer Risk in a Chilean Population

Autor: de la Rosa, R, Steinmaus, C, Akers, NK, Conde, L, Ferreccio, C, Kalman, D, Zhang, KR, Skibola, CF, Smith, AH, Zhang, L, Smith, MT

Publikováno v: de la Rosa, R; Steinmaus, C; Akers, NK; Conde, L; Ferreccio, C; Kalman, D; et al.(2018). Associations between Arsenic (13 Oxidation State) Methyltransferase (AS3MT) and N-6 Adenine-specific DNA Methyltransferase1 (N6AMT1) Polymorphisms, Arsenic Metabolism, and Cancer Risk in a Chilean Population.. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 59, 92-92. UC Berkeley: Retrieved from: http://www.escholarship.org/uc/item/9dt19706
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, vol 59

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::31ac4489be45c61d9b8e377d62cebc5f
http://www.escholarship.org/uc/item/9dt19706

Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.

Autor: Ching T; Computational Biology, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Duncan ME; Regulatory Affairs, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Newman-Eerkes T; Research and Development, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., McWhorter MME; Laboratory Operations Improvement, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Tracy JM; Research and Development, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Steen MS; Molecular Product Development, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Brown RP; Research and Development, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Venkatasubbarao S; Molecular Product Development, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Akers NK; Molecular Product Development, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Vignali M; Computational Biology, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Moorhead ME; Research and Development, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Watson D; Independent Consultant, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Emerson RO; Antigen Map, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Mann TP; Software Engineering, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Cimler BM; Regulatory Affairs, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Swatkowski PL; Regulatory Affairs, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Kirsch IR; Translational Medicine, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Sang C; Clinical Diagnostics, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Robins HS; Innovation, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Howie B; Computational Biology, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA., Sherwood A; Research and Development, Adaptive Biotechnologies Corporation, 1551 Eastlake Ave. E, Suite 200, Seattle, WA, 98102, USA. asherwood@adaptivebiotech.com.

Publikováno v: BMC cancer [BMC Cancer] 2020 Jun 30; Vol. 20 (1), pp. 612. Date of Electronic Publication: 2020 Jun 30.

Integrative analysis of loss-of-function variants in clinical and genomic data reveals novel genes associated with cardiovascular traits.

Autor: Glicksberg BS; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; The Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, 94158, CA, USA., Amadori L; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; Cardiovascular Research Center and Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA., Akers NK; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA., Sukhavasi K; Department of Pathophysiology, Institute of Biomedicine and Translation Medicine, University of Tartu, Biomeedikum, Ravila 19, 50411, Tartu, Estonia., Franzén O; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; Clinical Gene Networks AB, Jungfrugatan 10, 114 44, Stockholm, Sweden.; Integrated Cardio Metabolic Centre, Department of Medicine, Karolinska Institutet, Novum, 14157, Huddinge, Sweden., Li L; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; The Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA., Belbin GM; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA., Ayers KL; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; Sema4, a Mount Sinai venture, Stamford, CT, 06902, USA., Shameer K; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; The Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA., Badgeley MA; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; The Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA., Johnson KW; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; The Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA., Readhead B; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; The Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA., Darrow BJ; Cardiovascular Research Center and Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA., Kenny EE; Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; Department of Preventive Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA., Betsholtz C; Department of Immunology, Genetics and Pathology, Uppsala University, 751 85, Uppsala, Sweden., Ermel R; Department of Cardiac Surgery, Tartu University Hospital, 1a Ludwig Puusepa Street, 50406, Tartu, Estonia., Skogsberg J; Integrated Cardio Metabolic Centre, Department of Medicine, Karolinska Institutet, Karolinska Universitetssjukhuset Huddinge, 141 86, Stockholm, Sweden., Ruusalepp A; Clinical Gene Networks AB, Jungfrugatan 10, 114 44, Stockholm, Sweden.; Department of Immunology, Genetics and Pathology, Uppsala University, 751 85, Uppsala, Sweden., Schadt EE; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; The Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; Clinical Gene Networks AB, Jungfrugatan 10, 114 44, Stockholm, Sweden.; Sema4, a Mount Sinai venture, Stamford, CT, 06902, USA., Dudley JT; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; The Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; Department of Health Policy and Research, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA., Ren H; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Center for Diabetes and Metabolic Diseases, Stark Neurosciences Research Institute, Indiana University, 635 Barnhill Dr., MS2049, Indianapolis, IN, 46202, USA., Kovacic JC; Cardiovascular Research Center and Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA., Giannarelli C; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.; Cardiovascular Research Center and Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA., Li SD; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA. shuyudan.li@mssm.edu.; Sema4, a Mount Sinai venture, Stamford, CT, 06902, USA. shuyudan.li@mssm.edu., Björkegren JLM; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA. johan.bjorkegren@mssm.edu.; Department of Pathophysiology, Institute of Biomedicine and Translation Medicine, University of Tartu, Biomeedikum, Ravila 19, 50411, Tartu, Estonia. johan.bjorkegren@mssm.edu.; Clinical Gene Networks AB, Jungfrugatan 10, 114 44, Stockholm, Sweden. johan.bjorkegren@mssm.edu.; Integrated Cardio Metabolic Centre, Department of Medicine, Karolinska Institutet, Karolinska Universitetssjukhuset Huddinge, 141 86, Stockholm, Sweden. johan.bjorkegren@mssm.edu., Chen R; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA. rong.chen@mssm.edu.; Sema4, a Mount Sinai venture, Stamford, CT, 06902, USA. rong.chen@mssm.edu.

Publikováno v: BMC medical genomics [BMC Med Genomics] 2019 Jul 25; Vol. 12 (Suppl 6), pp. 108. Date of Electronic Publication: 2019 Jul 25.

Associations between arsenic (+3 oxidation state) methyltransferase (AS3MT) and N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms, arsenic metabolism, and cancer risk in a chilean population.

Autor: de la Rosa R; Superfund Research Program, Divisions of Environmental Health Sciences and Epidemiology, School of Public Health, University of California, Berkeley, California., Steinmaus C; Superfund Research Program, Divisions of Environmental Health Sciences and Epidemiology, School of Public Health, University of California, Berkeley, California., Akers NK; Superfund Research Program, Divisions of Environmental Health Sciences and Epidemiology, School of Public Health, University of California, Berkeley, California., Conde L; Superfund Research Program, Divisions of Environmental Health Sciences and Epidemiology, School of Public Health, University of California, Berkeley, California., Ferreccio C; Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Católica de Chile, Advanced Center for Chronic Diseases, ACCDiS, Santiago, Chile., Kalman D; Department of Environmental & Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington, DC., Zhang KR; Superfund Research Program, Divisions of Environmental Health Sciences and Epidemiology, School of Public Health, University of California, Berkeley, California., Skibola CF; Superfund Research Program, Divisions of Environmental Health Sciences and Epidemiology, School of Public Health, University of California, Berkeley, California., Smith AH; Superfund Research Program, Divisions of Environmental Health Sciences and Epidemiology, School of Public Health, University of California, Berkeley, California., Zhang L; Superfund Research Program, Divisions of Environmental Health Sciences and Epidemiology, School of Public Health, University of California, Berkeley, California., Smith MT; Superfund Research Program, Divisions of Environmental Health Sciences and Epidemiology, School of Public Health, University of California, Berkeley, California.

Publikováno v: Environmental and molecular mutagenesis [Environ Mol Mutagen] 2017 Jul; Vol. 58 (6), pp. 411-422. Date of Electronic Publication: 2017 Jun 22.

Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.

Autor: Skibola CF; Department of Epidemiology, School of Public Health and Comprehensive Cancer Center, Birmingham, AL 35233, USA; Division of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, CA 94720, USA. Electronic address: cskibola@uab.edu., Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Vijai J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Conde L; Department of Epidemiology, School of Public Health and Comprehensive Cancer Center, Birmingham, AL 35233, USA; Division of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, CA 94720, USA., Wang Z; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, MD 20877, USA., Yeager M; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, MD 20877, USA., de Bakker PI; Department of Medical Genetics and of Epidemiology, University Medical Center Utrecht, Utrecht 3584 CG, the Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht 3584 CX, the Netherlands., Birmann BM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Vajdic CM; Prince of Wales Clinical School, University of New South Wales, Sydney, NSW 2052, Australia., Foo JN; Human Genetics, Genome Institute of Singapore, Singapore 138672, Singapore., Bracci PM; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA 94118, USA., Vermeulen RC; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht 3584 CX, the Netherlands; Institute for Risk Assessment Sciences, Utrecht University, Utrecht 3508 TD, the Netherlands., Slager SL; Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA., de Sanjose S; Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Catala d'Oncologia, IDIBELL, Barcelona 8907, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona 8036, Spain., Wang SS; Department of Cancer Etiology, City of Hope Beckman Research Institute, Duarte, CA 91030, USA., Linet MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Salles G; Department of Hematology, Hospices Civils de Lyon, Pierre benite Cedex 69495, France; Department of Hematology, Université Lyon-1, Pierre benite Cedex 69495, France; Laboratoire de Biologie Moléculaire de la Cellule UMR 5239, Centre National de la Recherche Scientifique, Pierre benite Cedex 69495, France., Lan Q; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Severi G; Human Genetics Foundation, Turin 10126, Italy; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC 3053, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Carlton, VIC 3010, Australia., Hjalgrim H; Department of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen 2300, Denmark., Lightfoot T; Department of Health Sciences, University of York, York YO10 5DD, UK., Melbye M; Department of Epidemiology Research, Division of Health Surveillance and Research, Statens Serum Institut, Copenhagen 2300, Denmark; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA., Gu J; Department of Epidemiology, M.D. Anderson Cancer Center, Houston, TX 77030, USA., Ghesquières H; Laboratoire de Biologie Moléculaire de la Cellule UMR 5239, Centre National de la Recherche Scientifique, Pierre benite Cedex 69495, France; Department of Hematology, Centre Léon Bérard, Lyon 69008, France., Link BK; Department of Internal Medicine, Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA., Morton LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Holly EA; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA 94118, USA., Smith A; Department of Health Sciences, University of York, York YO10 5DD, UK., Tinker LF; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98117, USA., Teras LR; Epidemiology Research Program, American Cancer Society, Atlanta, GA 30303, USA., Kricker A; Sydney School of Public Health, The University of Sydney, Sydney, NSW 2006, Australia., Becker N; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg 69120, Germany., Purdue MP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Spinelli JJ; Cancer Control Research, BC Cancer Agency, Vancouver, BC V5Z 1L3, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Zhang Y; Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT 06520, USA., Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC 3053, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Carlton, VIC 3010, Australia., Vineis P; Human Genetics Foundation, Turin 10126, Italy; MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W2 1PG, UK., Monnereau A; Environmental Epidemiology of Cancer Group, Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Villejuif Cedex 94807, France; UMRS 1018, Université Paris Sud, Villejuif Cedex 94807, France; Registre des hémopathies malignes de la Gironde, Institut Bergonié, Bordeaux Cedex 33076, France., Bertrand KA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA., Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Zeleniuch-Jacquotte A; Department of Population Health, New York University School of Medicine, New York, NY 10016, USA; Cancer Institute, New York University School of Medicine, New York, NY 10016, USA., Gabbas A; Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Monserrato, Cagliari 09042, Italy., Chung CC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Burdett L; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, MD 20877, USA., Hutchinson A; Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Gaithersburg, MD 20877, USA., Lawrence C; Health Studies Sector, Westat, Rockville, MD 20850, USA., Montalvan R; Health Studies Sector, Westat, Rockville, MD 20850, USA., Liang L; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA; Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA., Huang J; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA., Ma B; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA; College of Information Science and Technology, Dalian Maritime University, Dalian, Liaoning Province 116026, China., Liu J; Human Genetics, Genome Institute of Singapore, Singapore 138672, Singapore., Adami HO; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden., Glimelius B; Department of Oncology and Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm 17176, Sweden; Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala 75105, Sweden., Ye Y; Department of Epidemiology, M.D. Anderson Cancer Center, Houston, TX 77030, USA., Nowakowski GS; Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA., Dogan A; Departments of Laboratory Medicine and Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Thompson CA; Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA., Habermann TM; Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA., Novak AJ; Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA., Liebow M; Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA., Witzig TE; Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA., Weiner GJ; Department of Internal Medicine, Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA., Schenk M; Department of Family Medicine and Public Health Sciences, Wayne State University, Detroit, MI 48201, USA., Hartge P; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA., De Roos AJ; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98117, USA; Department of Environmental and Occupational Health, Drexel University School of Public Health, Philadelphia, PA 19104, USA., Cozen W; Department of Preventive Medicine, USC Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA; Norris Comprehensive Cancer Center, USC Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA., Zhi D; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35233, USA., Akers NK; Division of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, CA 94720, USA., Riby J; Department of Epidemiology, School of Public Health and Comprehensive Cancer Center, Birmingham, AL 35233, USA; Division of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, CA 94720, USA., Smith MT; Division of Environmental Health Sciences, University of California Berkeley School of Public Health, Berkeley, CA 94720, USA., Lacher M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Villano DJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Maria A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Roman E; Department of Health Sciences, University of York, York YO10 5DD, UK., Kane E; Department of Health Sciences, University of York, York YO10 5DD, UK., Jackson RD; Division of Endocrinology, Diabetes and Metabolism, The Ohio State University, Columbus, OH 43210, USA., North KE; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Carolina Center for Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Diver WR; Epidemiology Research Program, American Cancer Society, Atlanta, GA 30303, USA., Turner J; Department of Anatomical Pathology, Australian School of Advanced Medicine, Macquarie University, Sydney, NSW 2109, Australia; Department of Histopathology, Douglass Hanly Moir Pathology, Macquarie Park, NSW 2113, Australia., Armstrong BK; Sydney School of Public Health, The University of Sydney, Sydney, NSW 2006, Australia., Benavente Y; Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Catala d'Oncologia, IDIBELL, Barcelona 8907, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona 8036, Spain., Boffetta P; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Brennan P; Group of Genetic Epidemiology, Section of Genetics, International Agency for Research on Cancer, Lyon 69372, France., Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and MF MU, Brno 656 53, Czech Republic., Maynadie M; EA 4184, Registre des Hémopathies Malignes de Côte d'Or, University of Burgundy and Dijon University Hospital, Dijon 21070, France., Staines A; School of Nursing and Human Sciences, Dublin City University, Dublin 9, Ireland., McKay J; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer, Lyon 69372, France., Brooks-Wilson AR; Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z 1L3, Canada; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada., Zheng T; Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT 06520, USA., Holford TR; Department of Biostatistics, Yale School of Public Health, New Haven, CT 06520, USA., Chamosa S; Health Department, BioDonostia Research Institute, Basque Region 20014, Spain., Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg 69120, Germany., Kelly RS; MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W2 1PG, UK; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA., Ohlsson B; Department of Clinical Sciences, Division of Internal Medicine, Skåne University Hospital, Lund University, Malmö 205 02, Sweden., Travis RC; Cancer Epidemiology Unit, University of Oxford, Oxford OX3 7LF, UK., Weiderpass E; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, Breivika 9037, Norway; Cancer Registry of Norway, Oslo 0304, Norway; Department of Genetic Epidemiology, Folkhalsan Research Center, Helsinki 00250, Finland., Clavel J; Environmental Epidemiology of Cancer Group, Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Villejuif Cedex 94807, France; UMRS 1018, Université Paris Sud, Villejuif Cedex 94807, France., Giovannucci E; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA; Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA., Kraft P; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA; Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA., Virtamo J; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki 00271, Finland., Mazza P; Department of Hematology, Ospedale Nord, Taranto 74100, Italy., Cocco P; Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Monserrato, Cagliari 09042, Italy., Ennas MG; Department of Biomedical Science, University of Cagliari, Monserrato, Cagliari 09042, Italy., Chiu BC; Department of Health Studies, University of Chicago, Chicago, IL 60637, USA., Fraumeni JF Jr; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Nieters A; Center for Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg, Baden-Württemberg 79108, Germany., Offit K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Wu X; Department of Epidemiology, M.D. Anderson Cancer Center, Houston, TX 77030, USA., Cerhan JR; Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA., Smedby KE; Department of Medicine Solna, Karolinska Institutet, Stockholm 17176, Sweden., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA., Rothman N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

Publikováno v: American journal of human genetics [Am J Hum Genet] 2014 Oct 02; Vol. 95 (4), pp. 462-71.